Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 12/23/14 → 03/7/19 |
Funding
- RedHill Biopharma Limited: $74,795.00
Randomized, Placebo-Controlled, Phase 3 Trial of RHB-102 (Ondansetron 24mg Bimodal Release Tablets) for Vomiting due to Presumed Acute Gastroenteritis or Gastritis
- Singer, Adam (PI)
- Wright, Brian (CoPI)
Project: Research